BI 655066 versus placebo In a Multicenter randomized double-blind study in patients with Moderate to severe cHronic plAque psoriasis evaluatiNg the effiCacy and safety with randomized withdrawal and rE-treatment (IMMhance)

Administered By

Awarded By

Contributors

Start/End

  • March 1, 2016 - February 29, 2020